Astellas Announces Cancellation of Treasury Shares

Tokyo, Japan, May 12, 2014 - Astellas Pharma Inc. (Tokyo: 4503; President and CEO: Yoshihiko Hatanaka, hereinafter called "the Company") announced that at the meeting of the Board of Directors held today, a resolution was adopted that the Company will cancel its treasury shares, pursuant to Article 178 of the Japanese Corporate Law.
Particulars
1. Class of shares to be cancelled Common stock of the Company
2. Number of shares to be cancelled 25 million shares
(Representing 1.09% of issued shares prior to cancellation)
3. Cancellation date May 30, 2014
(Reference)
1. Following cancellation, the Company will have 2,259,823,175 issued shares.
2. Total number of the Company's treasury shares after cancellation will be 28,681,395. (Expected numbers of shares described above 1 and 2 are the converted numbers in accordance
with the stock split, as announced in its press release dated February 28, 2014, "Astellas Announces Stock Split and Partial Amendment to the Articles of Incorporation", on the basis of the issued shares and the Company's treasury shares as of March 31, 2014, respectively.)

#######

Contacts for inquiries or additional information

Astellas Pharma Inc. Corporate Communications

Tel: +81-3-3244-3201 Fax: +81-3-5201-7473 http://www.astellas.com/en

distributed by